                         SEQUENCE LISTING

<110>  CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
       UNIVERSITE LAVAL
       THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF 
       LEARNING/MCGILL UNIVERSITY
 
<120>  USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY AND
        TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS

<130>  G17004-00008

<150>  US 62/979,327
<151>  2020-02-20

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
tggagcatgt ggtttaattc ga                                                22


<210>  2
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
tgcgggactt aacccaaca                                                    19


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
actgagaggt tgaacggcca                                                   20


<210>  4
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
cctttacacc cagtaawtcc gga                                               23


<210>  5
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide


<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  n is a, c, g, or t

<400>  5
cctacgggng gcwgcag                                                      17


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
gactachvgg gtatctaatc c                                                 21


